Flow Cytometry Market, by Technology (Cell based and Bead based), by Product Type (Analyzer, Sorter, and Reagent & Consumables), by Application (Research, Clinical, and Industrial), by End User (Hospital, Clinical Testing Laboratories, and Research Labora

Flow Cytometry Market, by Technology (Cell based and Bead based), by Product Type (Analyzer, Sorter, and Reagent & Consumables), by Application (Research, Clinical, and Industrial), by End User (Hospital, Clinical Testing Laboratories, and Research Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Flow cytometry is a laser-based or impedance-based biophysical technology employed in cell counting, cell sorting, biomarker detection, and protein engineering. The process is conducted by suspending cells in a stream of fluid and passing them through an electronic detection apparatus. The simultaneous multiparametric analysis of the physical and chemical characteristics of particles is facilitated by a flow cytometer at a speed of up to thousands of particles per second. The process is used in the diagnosis of health disorders such as blood cancers along with several applications in basic research, clinical practice, and clinical trials. Flow cytometry facilitates study of the expression of cell surface and intracellular molecules along with characterization of different cell types in a heterogeneous cell population. Moreover, flow cytometry also allows simultaneous multi-parameter analysis of single cells. The combination of technological improvements, growing research activities in life science, and increasing clinical application of flow cytometry in diagnosis of HIV and cancer are some of the major factors that are expected to drive growth of the flow cytometry market over the forecast period.
Flow cytometry is continuously going through new developments with availability of robust photodetectors and new laser emitters, use of LED lamps as emitter, and changes in analytical capacity (multidimensional analysis software). Furthermore, new approaches combining existing technologies with routine laboratory procedures, such as imaging, which capture of images of cells possible in real time as they pass by the interrogation point are some of the major advancements in flow cytometry. The process also finds application in cytology, hematology, immunology, and microbiology, among other research fields. For instance, in June 2019, Agilent Technologies, Inc. introduced its Agilent NovoCyte Advanteon flow cytometer, developed by the ACEA Biosciences. The product enhanced the limitations of benchtop flow cytometry by providing better performance than other flow cytometers.
Market Dynamics
Flow cytometry is quite an unexplored field, which is rapidly advancing due to technological advancements in the recent past. The increasing FDA approval for various clinical test favors the growth of flow cytometry market in near future. For instance, in 2017 the use of flow cytometer in detection of leukemia & lymphoma cancers was approved by U.S. Food Drug & Administration (FDA). Therefore, rising prevalence of HIV and cancer are expected to drive growth of the market over the forecast period. For instance, according to the Leukemia & Lymphoma Society (LLS), in 2019, there were around 76,200 people in the U.S. who are expected to be diagnosed with leukemia, lymphoma or myeloma cancers.
Market players are focused on launching technologically advanced products in the market, which is expected to fuel the market growth over the forecast period. For instance, in March 2019, BD (Becton, Dickinson and Company) launched BD FACSDuet, an automated flow cytometry system. The product is CE-IVD certified which enables clinical laboratories to improve their efficiency by reducing errors and limiting the manual user interactions required to run assays on the BD FACSLyric clinical flow cytometer.
Key features of the study:
This report provides in-depth analysis of the flow cytometry market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global flow cytometry market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as part of this study include Becton Dickinson and Company, General Electric Company, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH, Merck & Co Inc., Sysmex Corporation, Agilent Technologies, Inc., and Danaher Corporation.
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology upgradation, market expansion, and marketing tactics
The global flow cytometry market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the flow cytometry market
Detailed Segmentation:
Global Flow Cytometry market, By Technology:
Cell-Based
Bead-Based
Global Flow Cytometry market, By Product Type:
Analyzer
Sorter
Reagents & Consumables
Global Flow Cytometry market, By Application:
Research
Clinical
Industrial
Global Flow Cytometry market, By End User:
Hospital
Clinical Testing Laboratories
Research laboratories
Global Flow Cytometry market, By Region:
North America
By Technology:
Cell Based
Bead Based
By Product Type:
Analyzer
Sorter
Reagents & Consumables
By Application:
Research
Clinical
Industrial
By End User:
Hospital
Clinical Testing Laboratories
Research laboratories
By Country:
U.S.
Canada
Latin America
By Technology:
Cell Based
Bead Based
By Product Type:
Analyzer
Sorter
Reagents & Consumables
By Application:
Research
Clinical
Industrial
By End User:
Hospital
Clinical Testing Laboratories
Research laboratories
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Technology:
Cell Based
Bead Based
By Product Type:
Analyzer
Sorter
Reagents & Consumables
By Application:
Research
Clinical
Industrial
By End User:
Hospital
Clinical Testing Laboratories
Research laboratories
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Technology:
Cell Based
Bead Based
By Product Type:
Analyzer
Sorter
Reagents & Consumables
By Application:
Research
Clinical
Industrial
By End User:
Hospital
Clinical Testing Laboratories
Research laboratories
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
By Technology:
Cell Based
Bead Based
By Product Type:
Analyzer
Sorter
Reagents & Consumables
By Application:
Research
Clinical
Industrial
By End User:
Hospital
Clinical Testing Laboratories
Research laboratories
By Country:
GCC
Israel
Rest of Middle East
Africa
By Technology:
Cell Based
Bead Based
By Product Type:
Analyzer
Sorter
Reagents & Consumables
By Application:
Research
Clinical
Industrial
By End User:
Hospital
Clinical Testing Laboratories
Research laboratories
By Country/Region:
North Africa
Central Africa
South Africa
Company Profiles
Becton Dickinson and Company*
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Market Strategies
General Electric Company
Luminex Corporation
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Miltenyi Biotec GmbH
Merck & Co Inc.
Sysmex Corporation
Agilent Technologies, Inc.
Danaher Corporation
“*” marked represents similar segmentation in other categories in the respective section.